Literature DB >> 4344251

Isolation of a herpes simplex virus-specific antigenic fraction which stimulates the production of neutralizing antibody.

G H Cohen, M Ponce de Leon, C Nichols.   

Abstract

Infection of mammalian cells with herpes simplex virus (HSV) results in the production of a number of virus-induced soluble antigens. Immunodiffusion analyses of the soluble antigen mixture (SAM) obtained from HSV-infected KB or BHK cells revealed at least six well-defined immunoprecipitin bands. Calcium phosphate chromatography (Brushite) was employed to separate one immunoprecipitin (designated CP-1) from the remaining viral and host antigens. We conclude that CP-1 is a viral-specific antigen because (i) specific antiserum, which had been repeatedly absorbed with uninfected cell extracts or serum components, still retained the capacity to react in gel diffusion with CP-1 antigen; (ii) anti-CP-1 serum reacted in gel diffusion with SAM, yielding one precipitin band in identity with the band formed against human gamma globulin; (iii) the CP-1 fraction stimulated the production of HSV-neutralizing antibody of high capacity. The last observation suggests that fraction CP-1 contains a biologically active structural component of the virus which is associated with the envelope. The CP-1 immunoprecipitin was separated from SAM by an alternative method by using a cyanogen bromide-linked immunosorbent prepared from anti-CP-1 gamma globulin. The observation that the CP-1 antigen isolated from the immunosorbent effectively blocked serum-neutralizing activity provided further evidence that neutralizing antibody was directed against CP-1. Acrylamide gel electrophoresis and immunological experiments suggest that the CP-1 antigen is in part a glycoprotein. The finding that CP-1 contains only one antigenic component of the virus will permit future biological studies to be made with a monoprecipitin antiserum. In addition, the techniques described in this paper represent initial steps in the purification of HSV antigens.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4344251      PMCID: PMC356573     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  The preparation of 'monoprecipitin' antisera to herpes virus specific antigens.

Authors:  D H Watson; P Wildy
Journal:  J Gen Virol       Date:  1969-03       Impact factor: 3.891

2.  The separation of herpes virus-specific antigens by polyacrylamide gel electrophoresis.

Authors:  D H Watson
Journal:  J Gen Virol       Date:  1969-03       Impact factor: 3.891

3.  Virus specific antigens in mammalian cells infected with herpes simplex virus.

Authors:  D H Watson; W I Shedden; A Elliot; T Tetsuka; P Wildy; D Bourgaux-Ramoisy; E Gold
Journal:  Immunology       Date:  1966-10       Impact factor: 7.397

4.  The relationship of the herpes simplex haemadsorption phenomenon to the virus growth cycle.

Authors:  J F Watkins
Journal:  Virology       Date:  1965-08       Impact factor: 3.616

5.  Molecular weight estimation of polypeptide chains by electrophoresis in SDS-polyacrylamide gels.

Authors:  A L Shapiro; E Viñuela; J V Maizel
Journal:  Biochem Biophys Res Commun       Date:  1967-09-07       Impact factor: 3.575

6.  Selective enzyme purification by affinity chromatography.

Authors:  P Cuatrecasas; M Wilchek; C B Anfinsen
Journal:  Proc Natl Acad Sci U S A       Date:  1968-10       Impact factor: 11.205

7.  The poxvirus antigens.

Authors:  W C Wilcox; G H Cohen
Journal:  Curr Top Microbiol Immunol       Date:  1969       Impact factor: 4.291

8.  Chemical coupling of peptides and proteins to polysaccharides by means of cyanogen halides.

Authors:  R Axén; J Porath; S Ernback
Journal:  Nature       Date:  1967-06-24       Impact factor: 49.962

9.  Equine antihapten antibody. The molecular weights of the subunits of equine immunoglobulins.

Authors:  P C Montgomery; K J Dorrington; J H Rockey
Journal:  Biochemistry       Date:  1969-03       Impact factor: 3.162

10.  Soluble antigens of vaccinia-infected mammalian cells. I. Separation of virus-induced soluble antigens into two classes on the basis of physical characteristics.

Authors:  G H Cohen; W C Wilcox
Journal:  J Bacteriol       Date:  1966-09       Impact factor: 3.490

View more
  34 in total

1.  Cellular and viral requirements for rapid endocytic entry of herpes simplex virus.

Authors:  Anthony V Nicola; Stephen E Straus
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

2.  Structural analysis of precursor and product forms of type-common envelope glycoprotein D (CP-1 antigen) of herpes simplex virus type 1.

Authors:  R J Eisenberg; C Hydrean-Stern; G H Cohen
Journal:  J Virol       Date:  1979-09       Impact factor: 5.103

3.  Detection of a virus-specific antigen on the surface of herpes simplex virus-transformed cells.

Authors:  C L Reed; G H Cohen; F Rapp
Journal:  J Virol       Date:  1975-03       Impact factor: 5.103

4.  Studies of Marek's disease herpesvirus and turkey herpesvirus specific common antigen which stimulates the production of neutralizing antibodies.

Authors:  M Onuma; T Mikami; T T Hayashi; K Okada; Y Fujimoto
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

5.  Localization of discontinuous epitopes of herpes simplex virus glycoprotein D: use of a nondenaturing ("native" gel) system of polyacrylamide gel electrophoresis coupled with Western blotting.

Authors:  G H Cohen; V J Isola; J Kuhns; P W Berman; R J Eisenberg
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

6.  Effect of tunicamycin on herpes simplex virus glycoproteins and infectious virus production.

Authors:  L I Pizer; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1980-04       Impact factor: 5.103

7.  Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM.

Authors:  A V Nicola; M Ponce de Leon; R Xu; W Hou; J C Whitbeck; C Krummenacher; R I Montgomery; P G Spear; R J Eisenberg; G H Cohen
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

8.  Localization of epitopes of herpes simplex virus type 1 glycoprotein D.

Authors:  R J Eisenberg; D Long; M Ponce de Leon; J T Matthews; P G Spear; M G Gibson; L A Lasky; P Berman; E Golub; G H Cohen
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

Review 9.  Herpes simplex virus Membrane Fusion.

Authors:  Darin J Weed; Anthony V Nicola
Journal:  Adv Anat Embryol Cell Biol       Date:  2017       Impact factor: 1.231

10.  Potent neutralizing activity associated with anti-glycoprotein D specificity among monoclonal antibodies selected for binding to herpes simplex virions.

Authors:  M F Para; M L Parish; A G Noble; P G Spear
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.